» Articles » PMID: 29625280

Long QT Syndrome Type 5-Lite: Defining the Clinical Phenotype Associated with the Potentially Proarrhythmic P.Asp85Asn-KCNE1 Common Genetic Variant

Overview
Journal Heart Rhythm
Publisher Elsevier
Date 2018 Apr 7
PMID 29625280
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Long QT syndrome (LQTS) genetic test reports commonly exclude potentially proarrhythmic common variants such as p.Asp85Asn-KCNE1.

Objective: The purpose of this study was to determine whether a discernible phenotype is associated with p.Asp85Asn-KCNE1 and whether relatively common KCNE1 variants underlie transient QT prolongation pedigrees with negative commercial LQTS genetic tests.

Methods: Retrospective review was used to compare demographics, symptomatology, and QT parameters of individuals with p.Asp85Asn-KCNE1 in the absence of other rare/ultra-rare variants in LQTS-susceptibility genes and those who underwent comprehensive LQTS genetic testing.

Results: Compared to the Genome Aggregation Database, p.Asp85Asn-KCNE1 was more prevalent in individuals undergoing LQTS genetic testing (33/1248 [2.6%] vs 1552/126,652 [1.2%]; P = .0001). In 19 of 33 patients (58%), only p.Asp85Asn-KCNE1 was observed. These patients were predominantly female (90% vs 62%; P = .01) and were less likely to experience syncope (0% vs 34%; P = .0007), receive β-blockers (53% vs 85%; P = .001), or require an implantable cardioverter-defibrillator (5.3% vs 33%; P = .01). However, they exhibited a similar degree of QT prolongation (QTc 460 ms vs 467 ms; P = NS). Whole exome sequencing of 2 commercially genotype-negative pedigrees revealed that p.Asp85Asn-KCNE1 and p.Arg36His-KCNE1 traced with a transient QT prolongation phenotype. Functional characterization of p.Arg36His-KCNE1 demonstrated loss of function, with a 47% reduction in peak I current density in the heterozygous state.

Conclusion: We provide further evidence that relatively common variants in KCNE1 may result in a mild QT phenotype designated as "LQT5-Lite" to distinguish such potentially proarrhythmic common variants (ie, functional risk alleles) from rare pathogenic variants that truly confer monogenic disease susceptibility, albeit with incomplete penetrance.

Citing Articles

Multisite Validation of a Functional Assay to Adjudicate Brugada Syndrome-Associated Variants.

Ma J, ONeill M, Richardson E, Thomson K, Ingles J, Muhammad A Circ Genom Precis Med. 2024; 17(4):e004569.

PMID: 38953211 PMC: 11335442. DOI: 10.1161/CIRCGEN.124.004569.


Multi-site validation of a functional assay to adjudicate Brugada Syndrome-associated variants.

Ma J, ONeill M, Richardson E, Thomson K, Ingles J, Muhammad A medRxiv. 2024; .

PMID: 38196587 PMC: 10775332. DOI: 10.1101/2023.12.19.23299592.


Post-mortem genetic testing in sudden cardiac death and genetic screening of relatives at risk: lessons learned from a Czech pilot multidisciplinary study.

Votypka P, Krebsova A, Norambuena-Poustkova P, Peldova P, Kucerova S, Kulvajtova M Int J Legal Med. 2023; 137(6):1787-1801.

PMID: 37178278 PMC: 10567875. DOI: 10.1007/s00414-023-03007-z.


Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathies.

ONeill M, Sala L, Denjoy I, Wada Y, Kozek K, Crotti L Genet Med. 2022; 25(3):100355.

PMID: 36496179 PMC: 9992222. DOI: 10.1016/j.gim.2022.12.002.


Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare Variants.

Kozek K, Wada Y, Sala L, Denjoy I, Egly C, ONeill M Circ Genom Precis Med. 2021; 14(4):e003289.

PMID: 34309407 PMC: 8373797. DOI: 10.1161/CIRCGEN.120.003289.


References
1.
Ackerman M, Tester D, Jones G, Will M, Burrow C, Curran M . Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003; 78(12):1479-87. DOI: 10.4065/78.12.1479. View

2.
Ackerman M, Splawski I, Makielski J, Tester D, Will M, Timothy K . Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm. 2005; 1(5):600-7. DOI: 10.1016/j.hrthm.2004.07.013. View

3.
Gouas L, Nicaud V, Chaouch S, Berthet M, Forhan A, Tichet J . Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet. 2007; 15(9):974-9. PMC: 2234597. DOI: 10.1038/sj.ejhg.5201866. View

4.
Marjamaa A, Newton-Cheh C, Porthan K, Reunanen A, Lahermo P, Vaananen H . Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med. 2008; 265(4):448-58. PMC: 2668713. DOI: 10.1111/j.1365-2796.2008.02026.x. View

5.
Nishio Y, Makiyama T, Itoh H, Sakaguchi T, Ohno S, Gong Y . D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol. 2009; 54(9):812-9. DOI: 10.1016/j.jacc.2009.06.005. View